Source: Business Wire

Press Release: The University of Sydney : NSW Health Funds Indee Labs' First Preclinical Study Into Gene-Modified Cell Therapy Manufacturing for Blood Cancer

SYDNEY & SAN FRANCISCO--(BUSINESS WIRE)--The NSW Medical Device Fund has awarded AUD$500,000 to Indee Labs to partner with the University of Sydney to trial its technology to manufacture curative therapeutics for blood cancer. The use of viruses is a major roadblock in progressing gene-modified cell therapies past regulatory approvals because it increases the cost and complexity of producing the treatments. Simplification using the method proposed by Indee Labs could make the whole process quic

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Belinda Hutchinson's photo - Chancellor of The University of Sydney


Belinda Hutchinson

CEO Approval Rating

- -/100

University of Sydney offers undergraduate, master's and doctoral degrees. Read more